EssilorLuxottica Société anonyme against Sanofi — live side-by-side technical comparison.
Prices as of 2026-09-23T15:36:14+00:00 UTC · updates daily
EL.PA leads 3 of the 5 windows we measure — over 1 month EL.PA is -7.3% and SNY -8.8%; over year to date EL.PA is -44.4% and SNY -14.0%.
| EL.PA | SNY | |
|---|---|---|
| Price | $149.95 | $41.66 |
| 1 day | +3.8%lead | -2.0% |
| 5 days | +3.3%lead | -2.2% |
| 1 month | -7.3%lead | -8.8% |
| 6 months | -22.3% | -7.0%lead |
| Year to date | -44.4% | -14.0%lead |
| 52-week position | 6% of range | 7% of range |
| 52-week range | $138.30–$323.80 | $40.89–$52.68 |
| vs 50-day average | below $159.21 | below $43.82 |
| vs 200-day average | below $199.87 | below $45.32 |
| RSI (14) | 45 | 25 |
| Next earnings | 2026-02-11 | 2026-10-30 |
EL.PA trades at $149.95, below its 50-day average of $159.21, and below the 200-day at $199.87. It sits at 6% of its 52-week range ($138.30–$323.80); 14-day RSI is 45, in neutral territory; an average session moves it about 2.6%. For levels, the first level overhead is $150.00 (0.0% away) and the first support below is $139.00 (7.3% down). On the checklist the page runs for every asset, 2 of 6 checks read bullish — the lean is bearish.
SNY trades at $41.66, below its 50-day average of $43.82, and below the 200-day at $45.32. It sits at 7% of its 52-week range ($40.89–$52.68); 14-day RSI is 25, in oversold territory; an average session moves it about 1.7%. For levels, the first level overhead is $42.31 (1.6% away) and the first support below is $41.33 (0.8% down). On the checklist the page runs for every asset, 0 of 6 checks read bullish — the lean is bearish.
EL.PA is the more volatile of the two — an average session moves it 2.6% against 1.7% for SNY, so an identical position size carries roughly 1.5× the daily risk.
The comparison turns on those levels: EL.PA clearing $150.00 or losing $139.00; SNY clearing $42.31 or losing $41.33. Until one of them gives way, the relative reading above stands.